Suchergebnisse - "Sabari, Joshua K"

PubPharm (36)

1

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

enthalten in: Cancer discovery | 2024

von Yaeger, R. | Uboha, N. | Pelster, M. | +14

2

Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ohri, N. | Jolly, S. | Cooper, B. | +13

3

Safety and Intracranial Activity of Adagrasib in Patients With KRASG12C-Mutated Non-Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial : A Case Series

enthalten in: JCO precision oncology | 2024

von Bernstein, E. | Luo, J. | Wang, K. | +3

4

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Tang, K. | Cho, B. | +126

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779

5

Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer : a phase 1 trial

enthalten in: Nature medicine | 2023

von Cho, B. | Kim, D. | Spira, A. | +21

6

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Negrao, M. | Spira, A. | Heist, R. | +9

7

Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Bekaii-Saab, T. | Yaeger, R. | Spira, A. | +9

CommentIn: ESMO Open. 2023 Aug;8(4):101591. - PMID 37393631

8

Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2023

von Thummalapalli, R. | Bernstein, E. | Herzberg, B. | +12

9

Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Park, K. | Sabari, J. | Haura, E. | +15

10

Seeing Beyond the Smoke : Reclassifying Lung Cancer by Smoking-Related Mutational Signatures

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Moreira, A. | Sabari, J.

CommentOn: J Thorac Oncol. 2023 Apr;18(4):487-498. - PMID 36528243